Thorsten Simon Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• The benefit of myeloablative chemotherapy with autologous stem cell transplantation in high-risk neuroblastoma patients is stable during long term follow-up. Results of the NB97 trial. — Parallel 10 High Risk Neuroblastoma
• I-131-meta-iodobenzylguanidine therapy improves survival in high-risk neuroblastoma patients with mIBG positive residual metastatic disease — Parallel 10 High Risk Neuroblastoma